Wolverine Trading, LLC Unity Biotechnology, Inc. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.29 $8,736 - $20,124	15,600 New	15,600 $9,000
Q1 2022 May 16, 2022	SELL	$0.72 - $1.86 $9,288 - $23,994	-12,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.3 - $3.17 $3,640 - $8,876	2,800 Added 27.72%	12,900 $18,000
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.5 $11,931 - $18,450	-4,100 Reduced 28.87%	10,100 $30,000
Q2 2021 Aug 06, 2021	BUY	$4.15 - $6.3 $58,930 - $89,460	14,200 New	14,200 $66,000
Q4 2020 Feb 12, 2021	SELL	$3.42 - $6.36 $38,646 - $71,868	-11,300 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$2.94 - $12.43 $33,222 - $140,459	11,300 New	11,300 $39,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.